GENE ONLINE|News &
Opinion
Blog

2026-04-08|

PowerBank Signs LOI with Nodiac.ai to Integrate Energy Assets with Modular Data Centers

by GOAI
Share To

PowerBank has entered into a Letter of Intent (LOI) with Nodiac.ai, a company specializing in modular data center solutions. The agreement outlines plans for collaboration aimed at leveraging PowerBank’s existing energy assets to support Nodiac.ai’s operations. This partnership could potentially generate additional revenue streams for PowerBank by utilizing its current infrastructure.

The LOI establishes the framework for discussions between the two companies, focusing on how PowerBank’s energy resources can integrate with Nodiac.ai’s modular data centers. Modular data centers are compact and scalable facilities designed to meet growing demands for efficient and flexible computing power. By aligning their capabilities, both companies aim to explore opportunities that could benefit from combining renewable energy sources with advanced data center technology. Further details regarding the financial terms or specific project timelines have not yet been disclosed.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
Japanese Researchers Identify Stem Cell Dynamics in Vocal Fold Tissue Maintenance and Repair
2026-04-16
Study Identifies Active Role of Skin Cells in Rabies Virus Replication and Transmission
2026-04-16
Contractor Fatality Halts Operations at ATEX Resources’ Valeriano Project in Chile
2026-04-15
Dual Inhibition of xCT and GGCT Induces Ferroptosis in Glioblastoma Cells
2026-04-15
Researchers Develop Method to Convert Ketones into Saturated Heterocycles for Pharmaceutical Applications
2026-04-15
Naturally Occurring Compounds Luteolin, Naringenin, and Scutellarin Identified as Potential Inhibitors of Breast Cancer-Linked Enzymes HDAC4 and HDAC8
2026-04-15
Scroll to Top